Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vidisha Vimal HinguDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Closure of Trading Window
the trading window for transactions in shares of the Company for all designated persons, their immediate relatives and all concerned will be closed from October 01, 2022 till the 48 hours after the declaration of un-audited financial results of the Company for the half year ended September 30, 2022. Vanta Bioscience Ltd - 540729 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Vidisha Rathod as Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Receipt Of Approval From Registrar Of Companies Granting Extension Of Time For Holding The 6Th AGM
Receipt of approval from Registrar of Companies, Hyderabad granting extension of time for holding the 6th AGM for FY 2021-22 Vanta Bioscience Ltd - 540729 - Application To ROC, Hyderabad For Seeking Extension Of Time For Conducting AGM For FY 2021-22
Application to ROC, Hyderabad for seeking extension of time for conducting AGM for FY 2021-22 Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of CS w.e.f 15.09.2022 Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Next hearing on 09.11.2022 Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Next hearing of NCLAT on 11.08.2022 Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Appeal filed in NCLAT - Updates regarding hearings on June 16, 2022 and June 17, 2022